Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bright Minds Biosciences | CSE | Salute | Ricerca medica e biotecnologica | 399,12 Mln CA$ | -60,4x | -1,69 | 57,44 CA$ | 6,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 30,6% Rialzo | Fai l’upgrade a Pro+ | |
Cybin | CBOE Canada | Salute | Ricerca medica e biotecnologica | 263,67 Mln CA$ | -1,8x | -0,14 | 13,14 CA$ | -3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Fennec Pharma | Toronto | Salute | Ricerca medica e biotecnologica | 245,78 Mln CA$ | -148,7x | -1,59 | 8,93 CA$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
NervGen Pharma | TSXV | Salute | Ricerca medica e biotecnologica | 222,17 Mln CA$ | -6,8x | 0,83 | 3,16 CA$ | 1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 42,4% Rialzo | Fai l’upgrade a Pro+ | |
Eupraxia Pharmaceuticals | Toronto | Salute | Ricerca medica e biotecnologica | 159,95 Mln CA$ | -3,5x | -0,17 | 4,49 CA$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Cardiol Therapeutics | Toronto | Salute | Ricerca medica e biotecnologica | 154,23 Mln CA$ | -3,5x | 0,19 | 1,89 CA$ | 4,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
ZEN Graphene | TSXV | Salute | Ricerca medica e biotecnologica | 146,73 Mln CA$ | -12,7x | -1,07 | 1,41 CA$ | 15,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Medicenna | Toronto | Salute | Ricerca medica e biotecnologica | 135,21 Mln CA$ | -5,1x | 0,04 | 1,73 CA$ | -7,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Oncolytics Biotec | Toronto | Salute | Ricerca medica e biotecnologica | 110,22 Mln CA$ | -3,7x | -0,14 | 1,43 CA$ | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Satellos Bioscience | Toronto | Salute | Ricerca medica e biotecnologica | 100,16 Mln CA$ | -3,4x | 0,17 | 0,88 CA$ | 1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 39,2% Rialzo | Fai l’upgrade a Pro+ | |
ME Therapeutics Holdings | CSE | Salute | Ricerca medica e biotecnologica | 70,90 Mln CA$ | 3 CA$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
Zyus Life Sciences | TSXV | Salute | Ricerca medica e biotecnologica | 63,20 Mln CA$ | -1,6x | 0,47 | 0,85 CA$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
MustGrow Biologics | TSXV | Salute | Ricerca medica e biotecnologica | 63 Mln CA$ | -372,5x | -2,7 | 1,22 CA$ | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Microbix Biosystems Inc. | Toronto | Salute | Ricerca medica e biotecnologica | 55,59 Mln CA$ | 15,8x | 0 | 0,41 CA$ | 2,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
KDA Group | TSXV | Salute | Ricerca medica e biotecnologica | 50,36 Mln CA$ | -6,6x | 0,05 | 0,28 CA$ | 3,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
NurExone Biologic | TSXV | Salute | Ricerca medica e biotecnologica | 48,21 Mln CA$ | -7,2x | -0,37 | 0,68 CA$ | 6,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Helix BioPharma Corp. | Toronto | Salute | Ricerca medica e biotecnologica | 47,55 Mln CA$ | -4,8x | 0,13 | 0,97 CA$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Avicanna | Toronto | Salute | Ricerca medica e biotecnologica | 36,37 Mln CA$ | -4,5x | -0,1 | 0,33 CA$ | 3,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Briacell Therapeutics | Toronto | Salute | Ricerca medica e biotecnologica | 34,48 Mln CA$ | -0,6x | -0,03 | 0,78 CA$ | 2,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Defence Therapeutics | CSE | Salute | Ricerca medica e biotecnologica | 30,57 Mln CA$ | 0,06 | 0,64 CA$ | 6,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Defence Therapeutics | CSE | Salute | Ricerca medica e biotecnologica | 30,57 Mln CA$ | 0,06 | 0,64 CA$ | 6,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Sona Nanotech | CSE | Salute | Ricerca medica e biotecnologica | 27,37 Mln CA$ | -8,1x | 0,05 | 0,25 CA$ | -2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Thiogenesis Therapeutics | TSXV | Salute | Ricerca medica e biotecnologica | 26,85 Mln CA$ | -7x | 4 | 0,59 CA$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Pharmala Biotech Holdings | CSE | Salute | Ricerca medica e biotecnologica | 19,99 Mln CA$ | 0,23 CA$ | -8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
Biovaxys Technology | CSE | Salute | Ricerca medica e biotecnologica | 18,94 Mln CA$ | -0,06 | 0,06 CA$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Sirona Biochem Corp | TSXV | Salute | Ricerca medica e biotecnologica | 17,14 Mln CA$ | -6,5x | 0,46 | 0,06 CA$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
BioMark Diagnostics Inc | CSE | Salute | Ricerca medica e biotecnologica | 15,59 Mln CA$ | -9,1x | 0,28 | 0,20 CA$ | 5,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Rakovina Therapeutics | TSXV | Salute | Ricerca medica e biotecnologica | 15,35 Mln CA$ | -2,2x | 0,37 | 0,17 CA$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Resverlogix Corp. | Toronto | Salute | Ricerca medica e biotecnologica | 14,03 Mln CA$ | -0,9x | -0,06 | 0,05 CA$ | -18,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
BetterLife Pharma Inc | CSE | Salute | Ricerca medica e biotecnologica | 13,82 Mln CA$ | -0,6x | 0,09 | 0,10 CA$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |